Brighton Jones LLC’s GSK GSK Stock Holding History

Brighton Jones LLC’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$414K	Buy	+7,506	New	+$407K	0.01%	777
2025 Q4	–	Sell	-5,749	Closed	-$248K	–	417
2025 Q3	$248K	Sell	5,749 -238	-4%	-$9.3K	0.01%	881
2025 Q2	$230K	Buy	+5,987	New	+$229K	0.01%	819
2025 Q1	–	Sell	-15,604	Closed	-$528K	–	723
2024 Q4	$528K	Buy	+15,604	New	+$562K	0.02%	376
2024 Q3	–	Sell	-6,999	Closed	-$269K	–	617
2024 Q2	$269K	Sell	6,999 -6,137	-47%	-$258K	0.01%	498
2024 Q1	$563K	Buy	+13,136	New	+$542K	0.02%	325
2014 Q3	–	Sell	-4,179	Closed	-$279K	–	210
2014 Q2	$279K	Sell	4,179 -634	-13%	-$42.9K	0.06%	145
2014 Q1	$321K	Sell	4,813 -442	-8%	-$29.9K	0.08%	127
2013 Q4	$351K	Buy	+5,255	New	+$341K	0.08%	121

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Brighton Jones LLC's GSK Position: Q1 2026 in Review

Brighton Jones LLC opened a new position in GSK (GSK) in Q1 2026: 7,506 shares worth $414K. The stake represents 0.01% of the portfolio and ranks #777 among its holdings. This is a return to the name: Brighton Jones LLC previously reported a position in GSK as recently as Q3 2025.

Brighton Jones LLC first reported a position in GSK in Q4 2013 and has held it in 9 quarters since. The position peaked at $563K in Q1 2024. 1,034 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

Brighton Jones LLC held 7,506 shares of GSK worth $414K as of Q1 2026.
GSK was a new Brighton Jones LLC position in Q1 2026.
GSK made up 0.01% of Brighton Jones LLC's portfolio in Q1 2026, its #777 holding.
Brighton Jones LLC first reported a position in GSK in Q4 2013 and has held it in 9 quarters since.
Brighton Jones LLC's GSK position peaked at $563K in Q1 2024.
1,034 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Brighton Jones LLC's 13F filing for Q1 2026, filed 28 Apr 2026.